Variant report
Variant | nsv889969 |
---|---|
Chromosome Location | chr8:4647134-4658410 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558217023 | chr8:4653220-4653221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6987623 | chr8:4653225-4653226 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs190028231 | chr8:4653232-4653233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182408398 | chr8:4653257-4653258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149330956 | chr8:4653260-4653261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568189130 | chr8:4653267-4653268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541045175 | chr8:4653277-4653278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552720913 | chr8:4653283-4653284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186727994 | chr8:4653286-4653287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191096859 | chr8:4653291-4653292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563390406 | chr8:4653297-4653298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184090528 | chr8:4653316-4653317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530621255 | chr8:4653327-4653328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542373184 | chr8:4653340-4653341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188726390 | chr8:4653368-4653369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569826726 | chr8:4653374-4653375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193198814 | chr8:4653413-4653414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144585474 | chr8:4653440-4653441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6995744 | chr8:4653473-4653474 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs533353414 | chr8:4653509-4653510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551629712 | chr8:4653517-4653518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570089324 | chr8:4653531-4653532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76056291 | chr8:4653534-4653535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185074849 | chr8:4653540-4653541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188394585 | chr8:4653556-4653557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34144685 | chr8:4653582-4653583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535372132 | chr8:4653590-4653591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148406234 | chr8:4653617-4653618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191841658 | chr8:4653620-4653621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375865208 | chr8:4653625-4653626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556789983 | chr8:4653628-4653629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77121850 | chr8:4653671-4653672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542434658 | chr8:4653678-4653679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560775078 | chr8:4653687-4653688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572686924 | chr8:4653693-4653694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188308662 | chr8:4653697-4653698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73661134 | chr8:4653710-4653711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533178908 | chr8:4653720-4653721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113282095 | chr8:4653755-4653756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551713593 | chr8:4653791-4653792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142307319 | chr8:4653793-4653794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116828766 | chr8:4653812-4653813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534566423 | chr8:4653816-4653817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554624768 | chr8:4653821-4653822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180710688 | chr8:4653827-4653828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145939657 | chr8:4653842-4653843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139889295 | chr8:4653843-4653844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114882054 | chr8:4653847-4653848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185848905 | chr8:4653850-4653851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556887225 | chr8:4653851-4653852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4653200-4654000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr8:4653200-4654400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr8:4653800-4654200 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr8:4654200-4654600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:4658400-4670600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |